Global Bone Growth Stimulators Market

Bone Growth Stimulators Market Size, Share, Growth Analysis, By Product(Bone Growth Stimulation Devices {External Bone Growth Stimulators (Pulsed electromagnetic field devices, Combined magnetic field devices, Capacitive coupling devices), Ultrasonic Bone Growth Stimulators), By Application(Spinal Fusion Surgeries, Delayed Union & Non-Union Bone Fractures, Oral & Maxillofacial Surgeries, Others), By End User(Hospitals & Ambulatory Surgical Centers, Home Care Settings, Academic & Research Institutes), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2314 | Region: Global | Published Date: September, 2024
Pages: 219 | Tables: 63 | Figures: 77

Bone Growth Stimulators Market Insights

Global Bone Growth Stimulators Market size was valued at USD 2.10 Billion in 2022 and is poised to grow from USD 2.20 billion in 2023 to USD 3.23 billion by 2031, at a CAGR of 4.9% during the forecast period (2024-2031).

Bone growth stimulation, a complementary therapy, has gained popularity, particularly for bone mending. For fractures that have not recovered on their own, bone stimulators are frequently employed. The number of bone fractures and sports-related injuries is gradually rising, which is driving up demand for bone growth stimulators all around the world. According to the National Spinal Cord Injury Statistical Centre (NSCISC), there are about 54 cases of spinal cord injury (SCI) per million people in the United States per year. Around the world, 250,000 to 500,000 persons get spinal cord injuries annually, according to a recent report from the National Centre for Biotechnology Information. Orthopaedic surgeries have benefited from bone growth stimulating technology and products. Numerous clinical research on bone morphogenetic protein has been started because of the market potential. These simulators are used extensively in many different fields, including spinal fusion, dentistry, maxillofacial, fracture repair, and many more. The market is expanding as a result of the increasing incidence of osteoarthritis and degenerative bone diseases. Additionally, due to the quick uptake and demand for platelet-rich plasma and bone morphogenetic proteins market growth is also anticipated to be aided by improved healing outcomes.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Bone Growth Stimulators Market size was valued at USD 2.10 Billion in 2022 and is poised to grow from USD 2.20 billion in 2023 to USD 3.23 billion by 2031, at a CAGR of 4.9% during the forecast period (2024-2031).

The competitive landscape for the bone growth stimulator industry contains information on each competitor. A business overview, financials, revenue generated, market potential, R&D investments, new market initiatives, global presence, production sites and facilities, production capacities, product launches, product breadth and depth, and application dominance are all included in the data. 'Zimmer Biomet Holdings, Inc. (US) ', 'Stryker Corporation (US) ', 'Medtronic plc (Ireland) ', 'Orthofix Medical Inc. (US) ', 'Bioventus LLC (US) ', 'Arthrex, Inc. (US) ', 'Smith & Nephew plc (UK) ', 'Elizur Corporation (US) ', 'Isto Biologics (US) ', 'Ossatec Benelux B.V. (Netherlands) ', 'Terumo Corporation (Japan) ', 'Bioventus LLC (US) ', 'Ember Therapeutics (US) ', 'Isto Biologics (US) ', 'Ossatec Benelux B.V. (Netherlands) ', 'BONESUPPORT AB (Sweden) ', 'Regen Lab SA (Switzerland) ', 'Cerapedics, Inc. (US) ', 'Orthocell Ltd. (Australia) ', 'Alphatec Spine, Inc. (US) ', 'Bone Therapeutics SA (Belgium) ', 'EndoStim, Inc. (US)'

The rising prevalence of orthopedic conditions, such as fractures, delayed unions, non-unions, and osteoporosis-related fractures, is a significant driver for the bone growth stimulators market. As the aging population grows and the incidence of orthopedic conditions rises, the demand for bone growth stimulators increases.

In the present, the bone growth stimulators industry is being influenced by various consequential developments. A standout tendency is the increase in demand for treatments that are more amiable to patients and less invasive. In order to promote bone mending, bone growth stimulators are becoming a more popular choice for both healthcare providers and patients due to their ability to serve as a less intrusive alternative to conventional surgical means. This inclination is particularly noticeable when treating orthopedic ailments like spinal fusion, fractures, and others.

In 2022, North America had a predominant share of USD 0.72 billion. For bone growth stimulators, North America is the largest market. The market is expanding in North America due to the increased incidence of orthopedic injuries and disorders, the aging population, and the rising demand for less invasive procedures. The main elements promoting regional domination are the rising costs of healthcare, the prevalence of related bone illnesses, and the occurrences of these conditions that call for the administration of bone growth stimulators. The high shares of this region will also be strongly impacted by the robust procedure volumes related to orthopedic disorders.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Bone Growth Stimulators Market

Report ID: SQMIG35A2314

$5,300
BUY NOW GET FREE SAMPLE